Costa Rica vs Nigeria: Prevalence rate of hypertension in women aged 30-79
Costa Rica
39.4
in 2019
Nigeria
39
in 2019
Costa Rica rank
88th
Nigeria rank
91st
Prevalence rate of hypertension in women aged 30-79 over time
- Costa Rica
- Nigeria
How they compare
Costa Rica currently reports 39.4 against 39 in Nigeria, a difference of 0.4.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Nigeria ahead.
Costa Rica ranks 88th and Nigeria ranks 91st of 195 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.57 | 36.04 | 0.53 | Costa Rica |
| 2000s | 39.71 | 37.37 | 2.34 | Costa Rica |
| 2010s | 40.35 | 38.52 | 1.83 | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Costa Rica or Nigeria?
- Costa Rica, at 39.4 against 39 in Nigeria as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Costa Rica and Nigeria?
- 0.4, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Nigeria?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Nigeria rank globally for prevalence rate of hypertension in women aged 30-79?
- Costa Rica ranks 88th and Nigeria ranks 91st of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.